Commentaries

07 December 2016

Funding a Biopharma Without Licensing

Untitled.png"Funding a Biopharma Without Licensing"Presented at Genesis 2016, London

by Linda Summerton, Senior Partner at TranScrip and CEO of Immodulon

Click thumbnail to download the presentation.

02 December 2016

The Case for Small Pharma: A Q&A With Immodulon’s Linda Summerton

Untitled.png  Linda Summerton, Senior Partner at TranScrip and CEO of Immodulon sets out the case for small pharma in this Q&A with Biotech Investing  News. The piece looks at the advantages of investing in small pharma; the challenges being faced by the sector for 2017; and why small pharma is critical to driving growth and innovation in the UK.

Click on the thumbnail to view

07 July 2016

Brexit and Regulatory Approval for Drugs in Europe - What Happens Now?

Q and A -Brexit and Regulatory Approval for Drugs in Europe - What Happens Now_07Jul2016_FRONT PAGE.jpg7th July 2016: Following the UK's European Union (EU) referendum, TranScrip has received many questions on what the impact is likely to be for pharmaceutical and biotech companies on the development and approval of future drugs. The following summarises TranScrip’s responses to these questions.

click on the thumbnail to download the complete commentary

19 February 2016

The age of virtual pharma: Challenges and solutions for investor directors and successful boards

Biotech2016

Watch TranScrip's workshop recording from the Biotech Showcase 2016 conference.

Video source: © Biotech Showcase

Click on the thumbnail to view the video.

20 December 2015

TranScrip's Flic Gabbay is interviewed by PharmaTelevision at Genesis 2015 on the current situation in drug development.

Get the Flash Player to see this video.
 
Challenging, Exciting, Virtual and Collaborative – just a few of the words TranScrip's Flic Gabbay used to describe the industry during her interview at Genesis 2015.
 
Watch Flic's interview here where she discusses the accelerating trend to abandon traditional development models.  She discusses the emergence of novel multi-stakeholder collaborations across basic research and through translational/full drug development and, in parallel, improving market access to new drugs.

 

Click on the thumbnail to view the video 

Video source: © PharmaTelevision 

 

08 April 2014

SMi Masterclass Series, part 3, hosted by TranScrip Partners

Tim-Joslin-SMi-Masterclass-8.4.14.pngForecasting the unknown, by Tim Joslin

click on the thumbnail to download the presentation

28 March 2014

Listen to Senior Partner, Tim Joslin talk about Forecasting the Unknown

Listen to Senior Partner, Tim Joslin talk about Forecasting the Unknown, 28th March 2014

click on the thumbnail to view the video

10 October 2013

UK Bioscience Forum, 10th October 2013, Life science opportunities in China

Lifescience-opportunities-in-China-UK-Bioscience-forum-FG-Oct-10th.pngUK Bioscience Forum, 10th October 2013, Life science opportunities in China, by Flic Gabbay

click on the thumbnail to download the presentation

23 August 2013

Summit on Medical Information, UITM Medical School, Malaysia, part 3

Medical-Diaspora.pngSummit on Medical Information, UITM Medical School, Malaysia – Sree Haran’s keynote speaker presentations, 19th – 23rd August 2013

click on the thumbnail to download the presentation

23 August 2013

Summit on Medical Information, UITM Medical School, Malaysia, part 2

Career-Pathways-in-Medicine.pngSummit on Medical Information, UITM Medical School, Malaysia – Sree Haran’s keynote speaker presentations, 19th – 23rd August 2013

click on the thumbnail to download the presentation

16 July 2013

New product trends, part 3 – Quality

Listen to John Ansell talking about new product trends part 3 – Quality

click on the thumbnail to view the video

11 June 2013

New Product Trends, part 2 – Attrition in Development

Listen to John Ansell talking about new Product Trends part 2 – Attrition in Development

click on the thumbnail to view the video

26 April 2013

China – a huge opportunity but where to start? – Pharmaphorum article by Flic Gabbay

China-pharamphorum-article-march-13.pngIn 2011, China represented a little over 5% of the $880bn world pharmaceutical market and is growing at 25-27% per year. However, in some parts of the industry, China is already a world leader as it is the biggest exporter of Active Pharmaceutical Ingredients (APIs) to the European pharmaceutical market.

click on the thumbnail to download the complete commentary

17 April 2013

How and why Product Potential is underestimated

John-Ansell-SMI-slides-17.4.13.pngHow and why Product Potential is underestimated – John Ansell, 17th April 2013, SMI Pharmaceutical Portfolio Lifecycle Management event

click on the thumbnail to download the presentation

03 April 2013

New Product trends – is the quantity of new products on the way up?

Listen to John Ansell talking about New Product trends – is the quantity of new products on the way up?

click on the thumbnail to view the video

07 November 2012

Next Generation Pharma Summit

NGP-DD-Summit-Slides-Thumbnail-04112012.pngFlic Gabbay’s Next Generation Pharma Summit slides – 5th-7th November, Milan, Italy.

click on the thumbnail to download the presentation

15 October 2012

Report on UKTI sponsored visit to Sweden 23/24/25 September 2012

Post-UKTI-Sweden-trip.pngA TranScrip Partners delegation was invited to join a recent visit organised by UK Trade & Investment with the objective to build bridges between the pharmaceutical and CRO industry in the UK and Sweden.

click on the thumbnail to download the complete commentary

02 October 2012

Tackling today’s fixed combinations

Listen to John Ansell talking about tackling today’s fixed combinations.

click on the thumbnail to view the video